skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency

Review

(2709) Views  (855) Full article downloads

Authors: Sabine Kroiss, Manuela Albisetti

Published Date March 2010 Volume 2010:4 Pages 51 - 60
DOI: http://dx.doi.org/10.2147/BTT.S3014

Sabine Kroiss, Manuela Albisetti

Division of Hematology, University Children’s Hospital, Zurich, Switzerland

Abstract: Protein C is one of the major inhibitors of the coagulation system that downregulate thrombin generation. Severe congenital protein C deficiency leads to a hypercoagulability state that usually presents at birth with purpura fulminans and/or severe venous and arterial thrombosis. Recurrent thrombotic events are commonly seen. From the 1990’s, several virus-inactivated human protein C concentrates have been developed. These concentrates currently constitute the therapy of choice for the treatment and prevention of clinical manifestations of severe congenital protein C deficiency. This review summarizes the available information on the use of human protein C concentrates in patients with severe congenital protein C deficiency.

Keywords: Congenital protein C deficiency, protein C concentrate, purpura fulminans








Readers of this article also read:

Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
Therapeutic vaccines for malignant brain tumors
Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review
Safety of etanercept in elderly subjects with rheumatoid arthritis
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed